120 related articles for article (PubMed ID: 14717786)
1. The effects of selective cytokine inhibitory drugs (CC-10004 and CC-1088) on VEGF and IL-6 expression and apoptosis in myeloma and endothelial cell co-cultures.
Molostvov G; Morris A; Rose P; Basu S; Muller G
Br J Haematol; 2004 Feb; 124(3):366-75. PubMed ID: 14717786
[TBL] [Abstract][Full Text] [Related]
2. Adherence of multiple myeloma cells to bone marrow stromal cells upregulates vascular endothelial growth factor secretion: therapeutic applications.
Gupta D; Treon SP; Shima Y; Hideshima T; Podar K; Tai YT; Lin B; Lentzsch S; Davies FE; Chauhan D; Schlossman RL; Richardson P; Ralph P; Wu L; Payvandi F; Muller G; Stirling DI; Anderson KC
Leukemia; 2001 Dec; 15(12):1950-61. PubMed ID: 11753617
[TBL] [Abstract][Full Text] [Related]
3. Microvesicles shed from bortezomib-treated or lenalidomide-treated human myeloma cells inhibit angiogenesis in vitro.
Guo HM; Sun L; Yang L; Liu XJ; Nie ZY; Luo JM
Oncol Rep; 2018 Jun; 39(6):2873-2880. PubMed ID: 29693175
[TBL] [Abstract][Full Text] [Related]
4. Thalidomide downregulates angiogenic genes in bone marrow endothelial cells of patients with active multiple myeloma.
Vacca A; Scavelli C; Montefusco V; Di Pietro G; Neri A; Mattioli M; Bicciato S; Nico B; Ribatti D; Dammacco F; Corradini P
J Clin Oncol; 2005 Aug; 23(23):5334-46. PubMed ID: 15939924
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effects of parthenolide on the angiogenesis induced by human multiple myeloma cells and the mechanism.
Kong F; Chen Z; Li Q; Tian X; Zhao J; Yu K; You Y; Zou P
J Huazhong Univ Sci Technolog Med Sci; 2008 Oct; 28(5):525-30. PubMed ID: 18846331
[TBL] [Abstract][Full Text] [Related]
6. [Human multiple myeloma cells stimulate differentiation of endothelial cells to form capillary-like networks in two different co-culture systems].
Wang YD; Hu Y; Sun CY; He WJ; Zhang XP
Zhonghua Xue Ye Xue Za Zhi; 2007 Jun; 28(6):375-8. PubMed ID: 17939401
[TBL] [Abstract][Full Text] [Related]
7. Influence of thalidomide on Bcl2 expression and proangiogenic cytokine levels in short-term culture of peripheral blood and bone marrow mononuclear cells of multiple myeloma patients.
Dmoszyńska A; Roliński J; Bojarska-Junak A; Mańko J; Jawniak D; Walter-Croneck A; Soroka-Wojtaszko M; Hus M
Pol J Pharmacol; 2001; 53(6):709-13. PubMed ID: 11985351
[TBL] [Abstract][Full Text] [Related]
8. Potential new therapeutics for Waldenstrom's macroglobulinemia.
Zeldis JB; Schafer PH; Bennett BL; Mercurio F; Stirling DI
Semin Oncol; 2003 Apr; 30(2):275-81. PubMed ID: 12720152
[TBL] [Abstract][Full Text] [Related]
9. Antimyeloma effects of a novel synthetic retinoid Am80 (Tamibarotene) through inhibition of angiogenesis.
Sanda T; Kuwano T; Nakao S; Iida S; Ishida T; Komatsu H; Shudo K; Kuwano M; Ono M; Ueda R
Leukemia; 2005 Jun; 19(6):901-9. PubMed ID: 15843826
[TBL] [Abstract][Full Text] [Related]
10. [The interaction of vascular endothelial growth factor and interleukin-6 in multiple myeloma].
Zhang L; Chen SL; Chen WM; Liu JW
Zhonghua Nei Ke Za Zhi; 2005 Feb; 44(2):85-8. PubMed ID: 15840215
[TBL] [Abstract][Full Text] [Related]
11. [Human multiple myeloma cell line RPMI8226 activates brain derived neurotrophic factor autocrine loop of co-cultured endothelial cells].
Wang YD; Hu Y; Sun CY; He WJ; Zhang XP
Zhonghua Xue Ye Xue Za Zhi; 2007 Apr; 28(4):235-8. PubMed ID: 17877199
[TBL] [Abstract][Full Text] [Related]
12. [In vitro inhibition and mechanism of multiple myeloma cells growth by thalidomide].
Li J; Luo SK; Hong WD; Huang JQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2002 Feb; 10(1):70-2. PubMed ID: 12513842
[TBL] [Abstract][Full Text] [Related]
13. Novel biologically based therapies for myeloma.
Anderson KC
Cancer J; 2001; 7 Suppl 1():S19-23. PubMed ID: 11504280
[TBL] [Abstract][Full Text] [Related]
14. Fucoidan inhibits angiogenesis induced by multiple myeloma cells.
Liu F; Luo G; Xiao Q; Chen L; Luo X; Lv J; Chen L
Oncol Rep; 2016 Oct; 36(4):1963-72. PubMed ID: 27498597
[TBL] [Abstract][Full Text] [Related]
15. Synergistic effect of regulatory T cells and proinflammatory cytokines in angiogenesis in the endometriotic milieu.
Wang XQ; Zhou WJ; Luo XZ; Tao Y; Li DJ
Hum Reprod; 2017 Jun; 32(6):1304-1317. PubMed ID: 28383711
[TBL] [Abstract][Full Text] [Related]
16. [Thalidomide inhibits the angiogenic activity of culture supernatants of multiple myeloma cell line].
Chen W; Zhu J; Mirshahi F; Soria J; Mirshahi M; Soria C
Zhonghua Xue Ye Xue Za Zhi; 2002 Oct; 23(10):520-3. PubMed ID: 12482348
[TBL] [Abstract][Full Text] [Related]
17. Thalidomide and multiple myeloma serum synergistically induce a hemostatic imbalance in endothelial cells in vitro.
Gao Y; Ma G; Liu S; Teng Y; Wang Y; Su Y
Thromb Res; 2015 Jun; 135(6):1154-9. PubMed ID: 25840743
[TBL] [Abstract][Full Text] [Related]
18. Downmodulation of ERK protein kinase activity inhibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis.
Giuliani N; Lunghi P; Morandi F; Colla S; Bonomini S; Hojden M; Rizzoli V; Bonati A
Leukemia; 2004 Mar; 18(3):628-35. PubMed ID: 14737074
[TBL] [Abstract][Full Text] [Related]
19. Anti-angiogenic effects of ribonucleic acid interference targeting vascular endothelial growth factor and hypoxia-inducible factor-1alpha.
Forooghian F; Das B
Am J Ophthalmol; 2007 Nov; 144(5):761-8. PubMed ID: 17869204
[TBL] [Abstract][Full Text] [Related]
20. Myeloma cell-osteoclast interaction enhances angiogenesis together with bone resorption: a role for vascular endothelial cell growth factor and osteopontin.
Tanaka Y; Abe M; Hiasa M; Oda A; Amou H; Nakano A; Takeuchi K; Kitazoe K; Kido S; Inoue D; Moriyama K; Hashimoto T; Ozaki S; Matsumoto T
Clin Cancer Res; 2007 Feb; 13(3):816-23. PubMed ID: 17289872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
